Dava Pharmaceuticals agreed to pay 11 million to settle multistate litigation alleging that it misclassified drugs to evade paying its rebate obligations to Medicaid. The settlement also involved the federal government, which issued its own announcement; ###-dava-pharmaceuticals-inc